⏳ Fetching live dividend data...
Home › Calculator › SURF Dividend Calculator 2026
Surface Oncology, Inc. · NASDAQ
Price: $1.07 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in SURF → $386596.32M in 10 years · $30,225,951,477.20/month
Surface Oncology, Inc. is a clinical-stage biotechnology firm focused on discovering and developing innovative immuno-oncology treatments for cancer patients in the United States. Its pipeline features a range of antibody-based therapeutics, including NZV930, a fully human IgG4 monoclonal antibody designed to modulate extracellular adenosine production, and SRF617, another human IgG4 monoclonal antibody that aims to block CD39's enzymatic activity, thereby influencing adenosine levels and ATP degradation. Other key candidates include SRF388, which targets interleukin 27; GSK4381562, an antibody aimed at CD112R, an inhibitory protein found on natural killer and T cells; and SRF114, which targets the chemokine receptor CCR8. The company also maintains strategic partnerships, holding a licensing agreement with GlaxoSmithKline Intellectual Property (No. 4) Limited for the development, manufacturing, and commercialization of SRF813-targeting antibodies. Furthermore, it has a separate licensing deal with Vaccinex, Inc. concerning the development, production, and commercialization of antibodies targeting SRF114. Established in 2014, Surface Oncology, Inc. operates from its headquarters in Cambridge, Massachusetts.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open SURF position with:
Real after-tax yield depends on where you live and how you hold SURF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 186.92% | 184.12% | $18,692 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 158.88% | 156.08% | $15,888 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 149.54% | 146.74% | $14,954 / yr |
| 🇬🇧 UK ISA | 0% | 186.92% | 184.12% | $18,692 / yr |
| 🇬🇧 UK Taxable | 8.75% | 170.56% | 167.76% | $17,056 / yr |
| 🇨🇦 TFSA | 0% | 186.92% | 184.12% | $18,692 / yr |
| 🇨🇦 CA Taxable | 25% | 140.19% | 137.39% | $14,019 / yr |
| 🇦🇺 Super (pension) | 15% | 158.88% | 156.08% | $15,888 / yr |
| 🇦🇺 AU Taxable | 30% | 130.84% | 128.04% | $13,084 / yr |
| 🇩🇪 DE Taxable | 26.375% | 137.62% | 134.82% | $13,762 / yr |
| 🇫🇷 FR Taxable | 30% | 130.84% | 128.04% | $13,084 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
SURF pays quarterly — 4 times per year. Next ex-div: TBD.
How SURF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for SURF sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| D-Return | 2023-09-08 | 113,636 | $0.35 | $39.8K | ||
| D-Return | 2023-09-08 | 45,453 | — | — | ||
| D-Return | 2023-09-08 | 50,000 | $0.69 | $34.5K | ||
| D-Return | 2023-09-08 | 23,884 | — | — | ||
| D-Return | 2023-09-08 | 44,971 | — | — | ||
| D-Return | 2023-09-08 | 150,000 | $0.69 | $103.5K | ||
| D-Return | 2023-09-08 | 87,212 | — | — | ||
| D-Return | 2023-09-08 | 150,000 | $0.69 | $103.5K | ||
| D-Return | 2023-09-08 | 129,222 | — | — | ||
| D-Return | 2023-09-08 | 101,915 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the SURF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →